LU74558A1 - - Google Patents

Info

Publication number
LU74558A1
LU74558A1 LU74558A LU74558A LU74558A1 LU 74558 A1 LU74558 A1 LU 74558A1 LU 74558 A LU74558 A LU 74558A LU 74558 A LU74558 A LU 74558A LU 74558 A1 LU74558 A1 LU 74558A1
Authority
LU
Luxembourg
Application number
LU74558A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of LU74558A1 publication Critical patent/LU74558A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU74558A 1975-03-17 1976-03-15 LU74558A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
LU74558A1 true LU74558A1 (fr) 1977-09-27

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74558A LU74558A1 (fr) 1975-03-17 1976-03-15

Country Status (21)

Country Link
JP (1) JPS51115910A (fr)
AR (1) AR222624A1 (fr)
AT (1) AT353415B (fr)
AU (1) AU505355B2 (fr)
CA (1) CA1073358A (fr)
CH (1) CH630257A5 (fr)
DD (1) DD124102A5 (fr)
DE (1) DE2611041A1 (fr)
DK (1) DK148344C (fr)
ES (1) ES446075A1 (fr)
FR (1) FR2304354A1 (fr)
GB (1) GB1546448A (fr)
GR (1) GR60341B (fr)
IE (1) IE43083B1 (fr)
LU (1) LU74558A1 (fr)
MC (1) MC1101A1 (fr)
NL (1) NL190313C (fr)
NZ (1) NZ180321A (fr)
PH (1) PH14927A (fr)
PT (1) PT64907B (fr)
SE (1) SE433804B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
CZ286723B6 (cs) * 1991-01-30 2000-06-14 The Wellcome Foundation Limited Tablety dispergovatelné ve vodě
JP2626248B2 (ja) * 1991-04-08 1997-07-02 日本新薬株式会社 カプセル剤
JPH07507059A (ja) * 1992-03-25 1995-08-03 デポムド システムズ,インコーポレイテッド アルキル置換セルロースをベースとする持続放出性経口薬剤投与剤形
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
EP0725626A1 (fr) * 1993-10-29 1996-08-14 RECKITT & COLMAN PRODUCTS LIMITED Substance a pouvoir moussant garnissant une gelule de gelatine
ES2144532T3 (es) * 1993-10-29 2000-06-16 Scherer Corp R P Relleno de capsula de gelatina que puede formar espuma.
EP0759745A4 (fr) * 1994-05-13 1997-11-19 Smithkline Beecham Corp Methode et composition accroissant la fixation du calcium
EP0793485A4 (fr) * 1994-12-01 1998-08-26 Cibus Pharmaceutical Inc Administration de medicament a liberation prolongee comprenant une gomme hydrocolloide en poudre obtenue a partir de spermatophytes
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (fr) 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (fr) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
NZ180321A (en) 1978-06-20
PT64907A (fr) 1976-04-01
NL7602776A (nl) 1976-09-21
MC1101A1 (fr) 1977-02-04
DE2611041C2 (fr) 1988-06-09
FR2304354B1 (fr) 1979-04-27
AU1204976A (en) 1977-09-22
IE43083B1 (en) 1980-12-17
CA1073358A (fr) 1980-03-11
SE7603325L (sv) 1976-09-18
PT64907B (fr) 1978-03-24
AR222624A1 (es) 1981-06-15
DK113676A (da) 1976-09-18
DK148344B (da) 1985-06-17
FR2304354A1 (fr) 1976-10-15
CH630257A5 (en) 1982-06-15
DE2611041A1 (de) 1976-10-14
JPS638084B2 (fr) 1988-02-19
AT353415B (de) 1979-11-12
DK148344C (da) 1985-11-04
AU505355B2 (en) 1979-11-15
JPS51115910A (en) 1976-10-13
DD124102A5 (fr) 1977-02-02
NL190313B (nl) 1993-08-16
PH14927A (en) 1982-01-29
IE43083L (en) 1976-09-17
SE433804B (sv) 1984-06-18
GB1546448A (en) 1979-05-23
ATA192276A (de) 1979-04-15
NL190313C (nl) 1994-01-17
ES446075A1 (es) 1977-09-16
GR60341B (en) 1978-05-17

Similar Documents

Publication Publication Date Title
FR2304354B1 (fr)
JPS523290U (fr)
CH606522A5 (fr)
BG22163A1 (fr)
BG22188A1 (fr)
BG22198A1 (fr)
BG22953A1 (fr)
BG22978A1 (fr)
BG23120A1 (fr)
CH451575A4 (fr)
CH580780A5 (fr)
CH583874A5 (fr)
CH586969A5 (fr)
CH589356A5 (fr)
CH591012A5 (fr)
CH591144A5 (fr)
CH591173A5 (fr)
CH591335A5 (fr)
CH592012A5 (fr)
CH594131A5 (fr)
CH594324A5 (fr)
CH594920A5 (fr)
CH595677A5 (fr)
CH596290A5 (fr)
CH597658A5 (fr)